Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Technology
Share your love
Innovative VR Solution for Cataract Surgery Training
At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…
The Pineal Gland & The Eye of Horus I OBN
Since Galen, a Greek physician and philosopher, first recorded information on the pineal gland’s significance, it has been the focus of extensive research. Colleagues of Galen held the opinion that the pineal controlled the movement of “psychic pneuma,” an ethereal substance…
Zeiss Completes Acquisition of DORC
In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…
Melt Pharma Raises $24M for Sedation Tablet
Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…
CSI Dry Eye Software Unveils Version 5.0 Update
CSI Dry Eye Software, a leading innovator in the field of artificial intelligence for eye care, has officially announced the release of its latest software update, Version 5.0. This update marks a significant leap forward in the company’s mission to…
ViaLase Raises $40M for Glaucoma Laser Tech
ViaLase has successfully completed a Series C financing round, raising a substantial $40 million. This funding boost is set to accelerate the development, regulatory approval, and commercialization efforts of the ViaLase Laser, a pioneering medical device developed for the treatment…
Regenxbio’s Gene Therapy for Wet AMD Found Successful
Regenxbio Inc. announced the publication of their phase 1/2a study results in The Lancet, showcasing the effectiveness of ABBV-RGX-314 as a one-time gene therapy for wet age-related macular degeneration (AMD). Lancet Study Highlights Safety and Efficacy of ABBV-RGX-314 The study,…
Provectus & University of Miami Ink Deal on Eye Treatment
Provectus Biopharmaceuticals, Inc. has signed an exclusive global licensing agreement with the University of Miami. This partnership aims to harness the University’s pioneering photodynamic antimicrobial therapy (PDAT) for combating bacterial, fungal, and parasitic (acanthamoeba) eye infections. Launching a Start-Up for…
Algae-Derived Hydrogel Offers Hope for Retinal Detachment
A recent study has introduced an innovative approach to treating retinal detachment through an artificial vitreous body made from alginate, a natural carbohydrate extracted from algae. This research represents a collaboration among experts from Pohang University of Science and Technology…
The Intersection of Eye Imaging and Artificial Intelligence
In a review published in MedComm – Future Medicine, a research team led by Gao Yuanxu from Macau University of Science and Technology, with Miao Hanpei of Southern Medical University as the first author, sheds light on the promising intersection…